Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In this respect it is similar to cytisine and different from the nicotinic antagonist
NR2E1) modulator (EC50=1μM
is a small molecule integrin receptor antagonist (IRA) with potential antineoplastic activity
SNS-032 prevents tumor cell-induced VEGF secretion in a tumor coculture model
Affinity pulldown and kinase profiling studies implicate Erb3 binding protein-1 and the IκB kinase pathway in the mechanism of action of WS6
Paliperidone - CAS# 144598-75-4 Catalog No.:M11180-2 In this respect it isPaliperidone is a dopamine antagonist and 5 HT2A antagonist of the atypical antipsychotic class of medications. It is developed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once daily dosing. Paliperidone has antagonist effect at 1 and 2 adrenergic receptors and at H1 histamine receptors. It does not bind to muscarinic acetylcholine receptors. In addition,
US$ 175.00
US$ 16.28
US$ 23.30
US$ 235.50
US$ 16.36
US$ 14.35